Safety, Tolerability, and Efficacy of a Dose Reduction Strategy Based on Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-infected Adults
Clinical trial NCT05602506 · COMPLETED
Trial details
- NCT number
- NCT05602506
- Sponsor
- Fundacion Clinic per a la Recerca Biomédica
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-15
- Primary completion
- 2024-03-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.